ProfileGDS4132 / 234021_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 63% 60% 41% 44% 57% 63% 58% 60% 44% 47% 46% 49% 51% 50% 40% 45% 45% 44% 47% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101178.37963
GSM201543Muscle PCOS pioglitazone 121158.4260
GSM201544Muscle PCOS pioglitazone 161108.56941
GSM201545Muscle PCOS pioglitazone 201123.03544
GSM201829Muscle PCOS pioglitazone 231168.0257
GSM201830Muscle PCOS pioglitazon 251186.46163
GSM201831Muscle PCOS pioglitazone 271166.21358
GSM201832Muscle PCOS pioglitazone 31161.19160
GSM201833Muscle PCOS pioglitazone 41107.1744
GSM201834Muscle PCOS pioglitazone 81122.60847
GSM201835Muscle PCOS after pioglitazone 102106.32346
GSM201836Muscle PCOS after pioglitazone 122121.56949
GSM201837Muscle PCOS after pioglitazone 162117.83251
GSM201838Muscle PCOS after pioglitazone 202123.69550
GSM201839Muscle PCOS after pioglitazone 23295.612940
GSM201840Muscle PCOS after pioglitazone 252115.40545
GSM201841Muscle PCOS after pioglitazone 272104.23645
GSM201842Muscle PCOS after pioglitazone 3294.232544
GSM201843Muscle PCOS after pioglitazone 42118.58947
GSM201844Muscle PCOS after pioglitazone 82137.9152